Revenue: The sum of all revenue fields included for a company's operating activities.
Fate Therapeutics, Inc. (FATE) had Revenue of $1.37M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$1.37M |
$-32.37M |
|
-- |
|
$1.37M |
|
$36.09M |
|
$-34.72M |
|
$2.35M |
|
$-32.37M |
|
$-32.37M |
|
$-32.37M |
|
$-32.37M |
|
$-32.37M |
|
$-32.37M |
|
$-34.72M |
|
$-32.54M |
|
118.79M |
|
118.79M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$208.70M |
|
$56.92M |
|
$110.23M |
|
$318.94M |
|
$36.07M |
|
-- |
|
$75.68M |
|
$111.75M |
|
$207.18M |
|
$207.18M |
|
$207.18M |
|
115.36M |
|
| Cash Flow Statement Financials | |
$-106.08M |
|
$111.17M |
|
$5.49M |
|
$46.28M |
|
$56.85M |
|
$10.57M |
|
$24.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2536.23% |
|
-2536.23% |
|
-- |
|
-2364.79% |
|
-2364.79% |
|
$-111.67M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.49 |
|
60.22 |
|
-15.63% |
|
-15.63% |
|
-10.15% |
|
-15.63% |
|
$1.80 |
|
$-0.94 |
|
$-0.89 |
|